Respiratory Handbook
For UK audiences

The professional's guide to product selection

Montelukast - Almus Pharmaceuticals
Leukotriene receptor antagonists Montelukast Almus

Montelukast - Almus Pharmaceuticals

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Indications

For use in the management of exercise induced asthma and symptomatic relief of seasonal allergic rhinitis in patients with asthma.

Contraindications

Advised to avoid during pregnancy and breast feeding. However, if a person has significant improvement in their asthma from this medication prior to becoming pregnant they can continue.

Preparations Available

Granules, Tablets

Sizes Available

Granules
4 mg, sugar free, 28 sachets 

Tablets
10 mg, 28-tab pack 

Price

  •  

     

Leukotriene receptor antagonists

All Leukotriene receptor antagonists
Montelukast - Accord Healthcare
Accord Healthcare

Montelukast - Accord Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Alliance Healthcare
Alliance Healthcare

Montelukast - Alliance Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Bristol Laboratories Ltd
Bristol Laboratories

Montelukast - Bristol Laboratories Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Consilient Health
Consilient Health

Montelukast - Consilient Health

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Crescent Pharma Ltd
Crescent Pharma

Montelukast - Crescent Pharma Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - DE Pharmaceuticals
DE Pharmaceuticals

Montelukast - DE Pharmaceuticals

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast

All Montelukast
Montelukast - AAH Pharmaceuticals
AAH Pharmaceuticals

Montelukast - AAH Pharmaceuticals

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening
• Adult and child over 15 years: 10 mg once daily in the evening

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening

Montelukast - Accord Healthcare
Accord Healthcare

Montelukast - Accord Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Alliance Healthcare
Alliance Healthcare

Montelukast - Alliance Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Bristol Laboratories Ltd
Bristol Laboratories

Montelukast - Bristol Laboratories Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Consilient Health
Consilient Health

Montelukast - Consilient Health

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Crescent Pharma Ltd
Crescent Pharma

Montelukast - Crescent Pharma Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.